Hypothyroidism–Dysmorphism–Postaxial Polydactyly–Intellectual Disability Syndrome

Hypothyroidism–dysmorphism–postaxial polydactyly–intellectual disability syndrome is a rare genetic condition. Doctors most often call it Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) or the Young–Simpson syndrome, a variant within the broader Ohdo syndrome group. It is caused by harmful changes (pathogenic variants) in a single gene called KAT6B. This gene makes a histone acetyltransferase protein that helps switch other genes on and off during early growth. When KAT6B does not work well, body systems that need precise gene control—like the brain, face, skeleton, thyroid, heart, and genitals—can develop differently. Children commonly show distinctive facial features, congenital hypothyroidism, hypotonia (low muscle tone), developmental delay, and intellectual disability. Many also have skeletal findings such as postaxial polydactyly (an extra finger or toe on the little-finger/little-toe side) and small or absent kneecaps (patellar hypoplasia/agenesis). Heart defects, hearing loss, and feeding or breathing problems may also occur. The condition follows an autosomal dominant inheritance pattern, but most cases are due to new (de novo) mutations and are not inherited from a parent. Orpha.net+4NCBI+4MedlinePlus+4

This very rare genetic condition combines several features: low thyroid hormone levels from birth (congenital hypothyroidism), distinctive facial and body features (dysmorphism), extra fingers or toes on the outer side of the hands/feet (postaxial polydactyly), and learning or developmental disability. Many children also have weak muscle tone (hypotonia), small kneecaps or kneecaps that didn’t form, and sometimes heart defects. Doctors group it under the “SBBYS variant of Ohdo syndrome” or “Young–Simpson syndrome,” and you may see all of these names used in medical sources. There is no single “cure,” so care focuses on treating each medical need—especially early thyroid hormone replacement, supportive therapies, and surgeries for structural problems when indicated. bioportal.bioontology.org+4Orpha.net+4Genetic Rare Disease Center+4

---

Other names

Doctors and databases use several names for the same disorder:

• Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS)

• Young–Simpson syndrome

• SBBYS variant of Ohdo syndrome

• Blepharophimosis–intellectual disability syndrome, SBBYS type

• Hypothyroidism–dysmorphism–postaxial polydactyly–intellectual disability syndrome (descriptive name)

These names reflect the facial signs (blepharophimosis and a mask-like face), the developmental features, and the gene basis (KAT6B). Orpha.net+2Genetic Rare Disease Center+2

---

Types

There are no rigid official subtypes within SBBYSS itself, but experts describe a clinical spectrum across KAT6B-related disorders:

1. Classic SBBYSS phenotype. Mask-like face with blepharophimosis/ptosis, microcephaly, congenital hypothyroidism, long thumbs/great toes, patellar hypoplasia/agenesis, hypotonia, developmental delay, and possible heart, dental, hearing, and lacrimal anomalies. MedlinePlus+1

2. Intermediate KAT6B phenotype. Some children show features between SBBYSS and GPS. This happens because different variant locations in KAT6B can shift the clinical picture. NCBI+2ScienceDirect+2

3. Genitopatellar syndrome (GPS). Allelic to SBBYSS but with relatively more severe genital, patellar, and joint contracture findings and different facial traits; still part of the same gene spectrum. NCBI+1

Researchers also note genotype–phenotype patterns: truncating variants in certain KAT6B regions are linked with SBBYSS features, while variants elsewhere may produce GPS or intermediate findings. PMC+1

---

Causes

This syndrome has one primary cause—a pathogenic variant in KAT6B—but many mechanisms and contributors explain why features vary. Each point below is a short, plain-language “cause or contributor” to the overall condition or its severity.

1. KAT6B loss-of-function (haploinsufficiency). A damaged copy provides too little enzyme activity to regulate early development genes. MedlinePlus

2. Truncating variants in distal exons. Truncations toward the gene’s end often tie to the SBBYSS pattern. PMC

3. Nonsense-mediated decay. Some variants cause the cell to destroy faulty mRNA, cutting KAT6B protein levels. PMC

4. Missense variants with altered function. Certain missense changes can distort enzyme activity or interactions, modifying the phenotype. Karger Publishers

5. De novo mutation. Most affected children are the first in their family because a new variant arises in the egg or sperm. MedlinePlus

6. Parental germline mosaicism (rare). A parent may carry the variant in some reproductive cells, which can recur in siblings even if the parent seems unaffected. (General mechanism discussed across KAT6B reviews.) NCBI

7. Chromosomal rearrangements involving 10q22 (rare). Structural changes disrupting KAT6B can mimic KAT6B variant effects. (Reported within KAT6B disorder literature.) National Organization for Rare Disorders

8. Epigenetic dysregulation. KAT6B is a histone acetyltransferase; reduced acetylation alters gene expression programs during organ formation. MedlinePlus

9. Neurodevelopmental pathway impact. Reduced KAT6B activity affects brain development, contributing to hypotonia and intellectual disability. MedlinePlus

10. Skeletal development pathway impact. Gene dysregulation during limb and patella formation can cause polydactyly and patellar hypoplasia. MedlinePlus

11. Thyroid organogenesis impact. Disrupted developmental gene control can result in congenital hypothyroidism or thyroid agenesis. Genetic Rare Disease Center

12. Cardiac morphogenesis impact. Altered expression of cardiac development genes can lead to heart defects in some children. search.clinicalgenome.org

13. Craniofacial morphogenesis impact. Early patterning changes produce the mask-like face, blepharophimosis, and dental anomalies. MedlinePlus

14. Variant location within KAT6B. Different exons or domains can shift features toward SBBYSS, GPS, or an intermediate pattern. NCBI+1

15. Dominant-negative or gain-of-function effects (subset). Some missense variants may change enzyme behavior in special ways, altering the phenotype. Karger Publishers

16. Modifier genes (hypothesized). Other genes may temper severity, explaining variation between individuals with similar KAT6B variants. (Inference consistent with broad spectrum reports.) PMC

17. Early feeding and respiratory challenges. Hypotonia and craniofacial structure can worsen nutrition and growth, which then influence development. (Common clinical course note.) search.clinicalgenome.org

18. Hearing loss. Auditory issues can add to speech-language delays and learning problems. search.clinicalgenome.org

19. Vision problems. Ocular anomalies may affect motor development and learning. Wikipedia

20. Delayed diagnosis and late thyroid treatment. If hypothyroidism is not treated quickly, neurodevelopment can be further affected; early detection improves outcomes. (General principle plus SBBYSS hypothyroidism). MedlinePlus

---

Common symptoms and signs

1. Developmental delay. Children reach milestones later because brain development and muscle tone are affected. search.clinicalgenome.org

2. Intellectual disability. Learning and problem-solving can be harder, ranging from mild to severe. MedlinePlus

3. Congenital hypothyroidism. The thyroid makes too little hormone from birth; early treatment is important for growth and brain development. Genetic Rare Disease Center

4. Hypotonia. Low muscle tone leads to “floppy” feel in infancy, feeding issues, and later motor delays. search.clinicalgenome.org

5. Distinctive facial features. Mask-like expression, narrow eye openings (blepharophimosis), droopy eyelids (ptosis), prominent cheeks, and broad nasal bridge. MedlinePlus

6. Postaxial polydactyly. Extra finger or toe on the ulnar/fibular side; part of the skeletal pattern in some children. Genetic Rare Disease Center

7. Patellar hypoplasia/agenesis. Small or missing kneecaps can cause gait differences or knee instability. Genetic Rare Disease Center

8. Congenital heart defects. Holes between chambers or other structural issues may be present and need cardiology care. search.clinicalgenome.org

9. Hearing loss. Often bilateral and mixed; can affect speech learning without early support. Wikipedia

10. Ocular problems. Lacrimal gland anomalies, strabismus, and occasional retinal issues have been reported. MedlinePlus

11. Cleft palate (about one-third). An opening in the roof of the mouth can cause feeding and speech problems. MedlinePlus

12. Genital anomalies (often in males). Cryptorchidism or hypospadias may occur and require urologic care. Wikipedia

13. Dental anomalies. Tooth shape and eruption differences are part of the craniofacial pattern. MedlinePlus

14. Growth differences. Some children have postnatal growth delay and feeding challenges. Wikipedia

15. Breathing and feeding difficulties in infancy. Due to hypotonia, craniofacial structure, or airway features. NCBI

---

Diagnostic tests

A) Physical examination (bedside)

1. General pediatric exam. A careful head-to-toe check looks for facial features, posture, tone, growth, and any organ anomalies that point toward SBBYSS. NCBI

2. Facial and eye assessment. The clinician documents blepharophimosis, ptosis, and mask-like expression that are typical in SBBYSS. MedlinePlus

3. Muscle tone and reflexes. Hypotonia and delayed postural control are common and support the diagnosis. search.clinicalgenome.org

4. Cardiac auscultation and pulses. Murmurs or signs of heart defects prompt echocardiography. search.clinicalgenome.org

5. Genital and musculoskeletal exam. Cryptorchidism, patellar anomalies, long thumbs/toes, and extra digits are key clues. Genetic Rare Disease Center

B) Manual/functional assessments

6. Developmental screening (e.g., Denver II). Quick screens flag delays early so full testing can be arranged. (General developmental practice within KAT6B spectrum.) NCBI

7. Standardized developmental testing (e.g., Bayley Scales). Gives detailed cognitive, language, and motor profiles to guide therapy. (General approach in neurodevelopmental disorders.) NCBI

8. Feeding and swallowing evaluation. Speech-language pathologists assess suck, swallow, and safety if there is choking or poor weight gain. (Common in hypotonia syndromes, including KAT6B disorders.) search.clinicalgenome.org

9. Hearing-language assessment. Audiology and speech evaluations measure hearing levels and set therapy plans. search.clinicalgenome.org

10. Visual function assessment. Orthoptic and ophthalmology checks address strabismus, lacrimal issues, and visual tracking. MedlinePlus

C) Lab and pathological tests

11. Newborn screen and confirmatory thyroid labs. TSH and free T4 confirm congenital hypothyroidism and guide levothyroxine dosing. Genetic Rare Disease Center

12. Genetic testing for KAT6B. Targeted sequencing and deletion/duplication analysis detect the causative variant in most patients with typical features. NCBI

13. Exome or genome sequencing. Used when the presentation is atypical or when targeted tests are negative but suspicion remains. (Standard in rare disease diagnostics; applied widely in KAT6B disorders.) GIM Journal

14. Additional thyroid studies (thyroglobulin, imaging markers). Help distinguish thyroid agenesis from dyshormonogenesis when needed. (General hypothyroidism work-up in SBBYSS context.) Genetic Rare Disease Center

15. Basic metabolic panel and nutrition labs. Screens for dehydration, electrolyte imbalance, or poor growth consequences in infants with feeding issues. (Common supportive care.) search.clinicalgenome.org

D) Electrodiagnostic tests

16. EEG (if seizures or events). Looks for abnormal brain electrical activity when spells or development raise concern. (General neurodevelopmental practice.) NCBI

17. Auditory brainstem response (ABR). Objective measure of hearing in babies and nonverbal children; helpful when hearing loss is suspected. search.clinicalgenome.org

18. Nerve conduction/EMG (selected cases). Considered if severe hypotonia or neuromuscular disease is queried alongside central causes. (Occasional in hypotonia evaluation.) NCBI

E) Imaging tests

19. Echocardiogram. Ultrasound of the heart checks for structural defects commonly associated with KAT6B disorders. search.clinicalgenome.org

20. MRI of the brain and skeletal imaging. MRI can assess structural brain differences; X-rays or targeted imaging can confirm patellar hypoplasia and evaluate extra digits or long thumb/toe findings. NCBI+1

Non-pharmacological treatments (therapies & other supports)

1. Early thyroid care plan & newborn screening follow-through – Ensures prompt diagnosis and ongoing monitoring of congenital hypothyroidism, preventing avoidable cognitive and growth problems. Mechanism: tight lab-guided dosing plus family education improves hormone levels and outcomes. Genetic Rare Disease Center

2. Developmental (early-intervention) therapy – Speech-language, occupational, and physical therapy from infancy build communication, feeding, fine motor, and gross motor skills. Mechanism: neuroplasticity—the brain and muscles adapt best early with repetitive, guided practice. Genetic Rare Disease Center

3. Physiotherapy for hypotonia & joint stiffness – Strength, balance, and stretching programs reduce falls, support walking, and protect joints, especially when kneecaps are small or absent. Mechanism: progressive strengthening and range-of-motion work around altered biomechanics. Genetic Rare Disease Center

4. Orthotics & mobility aids – Custom foot orthoses, ankle-foot braces, or walkers stabilize gait and reduce energy cost of movement. Mechanism: external support corrects alignment and compensates for ligamentous laxity or patellar hypoplasia. Genetic Rare Disease Center

5. Feeding & swallowing therapy – Addresses weak mouth muscles and coordination; may use modified textures or special bottles. Mechanism: stepwise oral-motor training lowers choking risk and improves nutrition. NCBI

6. Special education & individualized learning plans – Tailors teaching pace and methods to the child’s cognitive profile. Mechanism: structured supports and repetition improve functional skills and independence. NCBI

7. Cardiology surveillance & activity guidance – Echocardiograms and tailored exercise advice when congenital heart defects are present. Mechanism: early detection and activity pacing prevent decompensation. Genetic Rare Disease Center

8. Ophthalmology & eyelid/ptosis management – Regular eye checks; taping, lubrication, or later eyelid surgery to protect the cornea when blepharophimosis/ptosis limits lid opening. Mechanism: preserving clear visual input protects visual development. Orpha.net

9. Hearing evaluation & communication supports – Audiology testing and hearing devices if needed; alternative communication strategies when speech is delayed. Mechanism: better auditory input supports language and social development. NCBI

10. Behavioral therapy & family training – Practical strategies for attention, anxiety, or sensory challenges that may accompany developmental disability. Mechanism: consistent routines and positive reinforcement improve daily function. NCBI

11. Nutritional counseling – Plans for adequate calories, protein, calcium and vitamin D to support growth and bones, adjusted around thyroid pill timing. Mechanism: macro-/micronutrient adequacy plus avoiding food-drug interactions. Office of Dietary Supplements

12. Dental and orthodontic care – Early dental hygiene and periodic orthodontic review address enamel and alignment issues sometimes seen with craniofacial differences. Mechanism: prevention reduces future pain and infection. Genetic Rare Disease Center

13. Respiratory & sleep assessment – Screening for sleep-disordered breathing in hypotonia or craniofacial dysmorphism; consider sleep studies. Mechanism: treating apnea improves daytime function and growth. NCBI

14. Social work & care coordination – Helps families navigate appointments, therapies, financial supports, and schooling. Mechanism: coordinated care reduces delays that worsen outcomes. Genetic Rare Disease Center

15. Genetic counseling – Explains inheritance, recurrence risk, and reproductive options. Mechanism: informed planning and testing for family members when appropriate. Genetic Rare Disease Center

16. Hand/foot therapy before and after surgery – Maximizes function in digits affected by polydactyly or syndactyly. Mechanism: edema control and targeted exercises optimize surgical results. Genetic Rare Disease Center

17. Orthopedic monitoring of patella and lower limbs – Periodic imaging and gait analysis to guide braces or surgery. Mechanism: early interventions prevent contractures and instability. Genetic Rare Disease Center

18. Vision and low-vision supports at school – Seating, lighting, print size, and assistive tech if eyelid or refractive issues reduce visual input. Mechanism: environmental adaptation improves learning access. Orpha.net

19. Safety planning & adaptive equipment at home – Gates, bathroom aids, and safe play areas for children with hypotonia/instability. Mechanism: reduces injury while encouraging activity. NCBI

20. Community & rare-disease networks – Connecting with rare-disease groups improves education and psychosocial support. Mechanism: shared resources reduce isolation and speed problem-solving. Genetic Rare Disease Center

---

Drug treatments

There is no single drug for the syndrome itself. Medicines below are FDA-approved for specific issues often present (e.g., congenital hypothyroidism or seizures). Always dose by your clinician’s guidance.

1. Levothyroxine (oral tablets) – Standard first-line for congenital hypothyroidism; replaces T4 to normalize TSH/T4 and support brain and body growth. Typical once-daily dosing on an empty stomach; pediatric weight-based dosing with close labs. Watch for over- or under-replacement symptoms; avoid giving with calcium/iron/soy close to the dose. FDA Access Data

2. Levothyroxine (IV) – Used when a child cannot take oral medication temporarily (e.g., severe illness). Mechanism: direct T4 replacement; IV dose is usually lower than oral because of full bioavailability. FDA Access Data+1

3. Liothyronine (Cytomel, T3) – Occasionally used in special situations under endocrinology supervision (e.g., diagnostic suppression tests, select replacement contexts). Shorter half-life and faster onset than T4; careful dosing to avoid tachycardia or irritability. FDA Access Data+1

4. Somatropin (recombinant growth hormone) – Considered if a child has a proven growth-hormone deficiency or specific FDA-labeled indications; improves linear growth with nightly subcutaneous injections and routine monitoring. FDA Access Data+1

5. Levetiracetam (Keppra) – Common first-line anti-seizure medicine in pediatrics (if seizures occur), available in liquid/tablet/IV forms; generally well-tolerated. Dose titrated by weight and response; watch for mood/behavior changes. FDA Access Data+2FDA Access Data+2

6. Valproate / Divalproex – Broad-spectrum anti-seizure option; effective for many seizure types but carries important boxed warnings (liver, pancreas, teratogenicity). Requires labs and careful risk discussions, especially in females of child-bearing potential. FDA Access Data+2FDA Access Data+2

7. Lamotrigine – Another anti-seizure medicine useful for generalized or focal epilepsies; slow titration reduces rash risk. Often used when levetiracetam is not tolerated. (Label citation available on request.)

8. Topiramate – Broad-spectrum anti-seizure; may help certain generalized seizures; monitor for appetite/weight changes and cognitive slowing. (Label citation available on request.)

9. Baclofen – For significant spasticity if present (some children alternate hypotonia/hypertonia); can improve comfort and care. Start low and titrate; monitor for sedation or weakness. (Label citation available on request.)

10. Rescue benzodiazepines (e.g., midazolam nasal) – For prolonged seizures per seizure action plan; rapid abortive therapy families can use at home/school. FDA Access Data

11. Proton-pump inhibitors or H2 blockers – If reflux complicates feeding or growth; reduce acid and esophagitis risk while feeding therapy progresses. (Label citations available on request.)

12. Vitamin D and calcium (when deficient) – Correct documented deficiencies to support bones, particularly in low mobility; time away from levothyroxine dose to avoid absorption interference. Office of Dietary Supplements

13. Iron (when deficient) – Treats iron-deficiency anemia to support energy and development; separate from levothyroxine by several hours. Office of Dietary Supplements

14. Iodine (only to correct deficiency, not to replace thyroid hormone) – Adequate iodine intake matters for thyroid hormone biology, but iodine is not a substitute for levothyroxine in congenital hypothyroidism. Office of Dietary Supplements

15. Topical eye lubricants – If incomplete eyelid opening causes exposure dryness; protects the cornea until surgical correction is considered. (OTC product selection per ophthalmology.)

16. Stool softeners/fiber agents – For constipation common in hypotonia/low mobility; improve comfort and feeding. (OTC; use pediatric guidance.)

17. Analgesics (acetaminophen/ibuprofen per weight) – For post-operative or musculoskeletal pain; follow pediatric dosing tables. (Label citations available on request.)

18. Antibiotics per standard indications – For otitis media or dental infections when they arise; not syndrome-specific, follow local guidelines.

19. Allergy meds (as needed) – Simplify ENT issues that can worsen feeding or sleep; avoid sedating choices that impede therapy sessions.

20. Fluoride varnish/drops as advised – Dental prevention plan for children at caries risk.

Important safety note: Drug choices above treat associated problems (e.g., hypothyroidism or seizures). They are prescribed only when those problems are present, and dosing is individualized.

---

Dietary molecular supplements

1. Vitamin D – Supports calcium absorption and bone health; deficiency is common in low sun exposure and limited mobility. Typical pediatric doses vary by age and level; avoid excess to prevent hypercalcemia. Office of Dietary Supplements+1

2. Calcium – Builds bones and teeth; coordinate timing far away from levothyroxine doses to prevent absorption issues. Dose depends on age/dietary intake. Office of Dietary Supplements

3. Iron – Corrects iron-deficiency anemia; improves energy and development. Separate from levothyroxine by several hours to avoid binding. Office of Dietary Supplements+2Office of Dietary Supplements+2

4. Iodine (dietary adequacy) – Ensure iodized salt or food sources if diet is deficient; do not replace prescribed thyroid hormone with iodine alone in congenital hypothyroidism. Office of Dietary Supplements+1

5. Selenium – Trace mineral involved in thyroid hormone metabolism; aim for recommended intakes, avoid high-dose supplementation unless a clinician advises it. Office of Dietary Supplements+1

6. Omega-3 fatty acids (EPA/DHA) – General support for heart and brain health; choose purified pediatric formulations when diet lacks fish. Mechanism: membrane and anti-inflammatory effects. Office of Dietary Supplements+1

7. Multivitamin (age-appropriate) – Fills small dietary gaps when feeding is selective; avoid iron/calcium near levothyroxine dose. Office of Dietary Supplements

8. Fiber (psyllium/inulin) – Helps constipation related to hypotonia and low mobility; increase fluids. (General nutrition guidance.)

9. Probiotic (selected strains) – May help stool regularity or antibiotic-associated diarrhea; choose products with pediatric data. (General evidence varies.)

10. Protein-energy supplements – For growth faltering; registered dietitian selects formula or powders to meet calorie/protein goals. (Clinical nutrition practice.)

---

Immunity-booster / Regenerative / Stem-cell” drugs

There are no FDA-approved immune boosters, regenerative, or stem-cell drugs for this syndrome. Research into tissue engineering or cell therapies for congenital structural problems is still experimental, and using such products outside regulated trials can be risky. Focus should remain on proven care: thyroid replacement, therapies, nutrition, surgeries when indicated, and vaccines per schedule. (If you hear of “stem-cell cures,” ask for trial registration and regulatory oversight details; avoid unapproved clinics.) [No specific FDA-approved products to cite because none exist for this indication.]

---

Surgeries

1. Excision of postaxial polydactyly / hand-foot reconstruction – Removes extra digits and rebalances tendons and ligaments to improve function, shoe wear, and appearance. Timing and method depend on digit anatomy. Genetic Rare Disease Center

2. Blepharophimosis/ptosis repair – Eyelid surgery to widen palpebral fissures and lift upper lids; protects the cornea and improves vision and facial openness. Orpha.net

3. Congenital heart defect repair – Catheter or open procedures (e.g., closing a septal defect) when cardiology deems necessary; prevents heart failure and improves growth. Genetic Rare Disease Center

4. Cryptorchidism (orchiopexy) – Brings undescended testis into the scrotum to protect fertility potential and ease monitoring. Genetic Rare Disease Center

5. Knee/patella procedures – Selected cases may need soft-tissue balancing or reconstruction to stabilize gait when patellae are hypoplastic/absent. Decision is individualized after conservative options. Genetic Rare Disease Center

---

Preventions

1. Newborn screening + rapid thyroid treatment prevents avoidable developmental harm. Genetic Rare Disease Center

2. Routine well-child visits catch vision, hearing, dental, and growth issues early. Genetic Rare Disease Center

3. Vaccination per schedule reduces hospitalizations that disrupt therapy progress.

4. Nutrition planning prevents under- or over-nutrition and supports bones. Office of Dietary Supplements

5. Therapy continuity (PT/OT/SLP) prevents regression of gains. Genetic Rare Disease Center

6. Eye protection and lubrication protect corneas before/after eyelid surgery. Orpha.net

7. Dental hygiene + fluoride prevent caries and pain that impede feeding/therapy.

8. Home safety adaptations reduce falls and injuries in hypotonia/instability. NCBI

9. Infection control (hand hygiene, prompt ENT/dental care) prevents setbacks.

10. Genetic counseling informs future pregnancy planning and recurrence risk. Genetic Rare Disease Center

---

When to see a doctor urgently vs. routinely

• Urgent: breathing trouble, blue lips, severe feeding problems/dehydration, seizure >5 minutes or repeated seizures without recovery, sudden eye pain/redness with light sensitivity, fever in infants <3 months, signs of thyroid overdose (fast heartbeat, irritability) or undertreatment (extreme sleepiness, poor feeding) after medication changes. FDA Access Data+2FDA Access Data+2

• Soon: new heart murmur or swelling, persistent vomiting/constipation affecting growth, recurrent ear infections or hearing changes, new falls/limp, vision concerns, dental pain. Genetic Rare Disease Center+1

• Routine: thyroid labs and growth checks per endocrinology schedule; annual vision/hearing/dental reviews; therapy progress checks every 3–6 months. Genetic Rare Disease Center

---

What to eat and what to avoid

1. Do aim for balanced meals with protein, fruits/vegetables, whole grains, and healthy fats; this supports growth and therapy stamina.

2. Do ensure calcium and vitamin D intake for bone health (milk/yogurt/fortified foods) but give them far away from levothyroxine. Office of Dietary Supplements

3. Do use iodized salt in typical amounts to maintain iodine adequacy. Office of Dietary Supplements

4. Do offer fiber-rich foods and water for bowel regularity.

5. Do work with a dietitian if feeding is selective to meet calories and protein.

6. Avoid giving levothyroxine with iron, calcium, or high-soy foods; separate by several hours. FDA Access Data

7. Avoid megadose supplements (e.g., high-dose vitamin D or selenium) unless a clinician prescribes them. Office of Dietary Supplements+1

8. Avoid choking-risk textures if swallowing is unsafe; follow speech-therapy guidance.

9. Avoid excessive sugary snacks/juices that displace nutrient-dense foods and harm teeth.

10. Avoid unregulated “thyroid boosters” or “stem-cell cures” marketed online. Stick to regulated care.

---

Frequently Asked Questions

1. Is there a cure? No single cure; care targets each problem (thyroid, vision, heart, mobility, learning) to maximize quality of life. Genetic Rare Disease Center

2. Will thyroid medication be lifelong? Congenital hypothyroidism is usually lifelong; endocrinology may re-evaluate in late infancy if indicated. FDA Access Data

3. Can early treatment improve development? Yes—early thyroid replacement and therapies support better cognitive and motor outcomes. Genetic Rare Disease Center

4. Is polydactyly harmful? Extra digits can affect function or footwear; many families choose surgical removal for function and comfort. Genetic Rare Disease Center

5. Why are eyelids important here? Narrow openings/ptosis can block vision and dry the eyes; ophthalmology protects sight and may do surgery. Orpha.net

6. Are seizures guaranteed? No. Some children have seizures; if present, standard pediatric anti-seizure medicines are used. FDA Access Data

7. What about growth? If growth hormone deficiency is proven and indications are met, somatropin may be considered under specialist care. FDA Access Data

8. Can school help? Yes—individualized education plans and therapies at school are key supports. NCBI

9. Will walking be delayed? Often; hypotonia and knee/foot issues can slow milestones, but PT/orthotics help progress. Genetic Rare Disease Center

10. Is it inherited? Genetic factors are involved; a genetic counselor explains patterns and family risks. Genetic Rare Disease Center

11. What specialists do we need? Endocrinology, cardiology, ophthalmology, orthopedics, genetics, therapy services, dentistry, audiology. Genetic Rare Disease Center

12. Any special precautions with thyroid pills? Give on an empty stomach; keep iron/calcium/soy several hours away; don’t double doses without advice. FDA Access Data

13. Are high-dose supplements helpful? Not routinely; use supplements to correct documented deficiencies and avoid megadoses. Office of Dietary Supplements+1

14. Can we exercise? Yes—activity plans are tailored to heart status and joint stability; movement builds strength and confidence. Genetic Rare Disease Center

15. Where can we learn more? Orphanet, NIH rare-disease pages, and MedGen summaries for clinicians are reliable overviews. Orpha.net+2Genetic Rare Disease Center+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 28, 2025.